polypeptide deformylase inhibitors (GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namepolypeptide deformylase inhibitors (GlaxoSmithKline)
Drug Alias NamePolypeptide Deformylase Inhibitors (GlaxoSmithKline/Medicines for Malaria Venture (MMV))SB-660618
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptide deformylase inhibitors
TargetsPeptide deformylase
Therapy Area/IndicationsRespiratory Tract InfectionsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcMedicines for Malaria Venture
Active IndicationsN/A
Inactive IndicationsRespiratory Tract InfectionsMalaria

Other Information

ATC CodeN/A
Related LinksN/A